No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Roivant Sciences Insider Sold Shares Worth $1,022,000, According to a Recent SEC Filing
Cantor Fitzgerald Initiates Roivant Sciences(ROIV.US) With Buy Rating
H.C. Wainwright Maintains Roivant Sciences(ROIV.US) With Buy Rating, Maintains Target Price $18
HC Wainwright & Co. Reiterates Buy on Roivant Sciences, Maintains $18 Price Target
Roivant Sciences Analyst Ratings
Strategic Advancements and Growth Potential Justify Buy Rating for Roivant Sciences